Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct 21;106(11):e4791-e4792.
doi: 10.1210/clinem/dgab515.

Response to Letter to the Editor From Laidlaw: "Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years"

Milou C Madsen  1   2 , Dennis van Dijk  1 , Chantal M Wiepjes  1   2 , Elfi B Conemans  1   2 , Abel Thijs  2 , Martin den Heijer  1   2
Affiliations
Comment

Response to Letter to the Editor From Laidlaw: "Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years"

Milou C Madsen et al. J Clin Endocrinol Metab. .
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

References

    1. Laidlaw M, van Mol A, van Meter Q, Hansen J. Letter to the Editor From M Laidlaw: “Erythrocytosis in a large cohort of trans men using testosterone: a long-term follow-up study on prevalence, determinants and exposure years.” J Clin Endocrinol Metab 2021. - PubMed
    1. Ozarda Y, Sikaris K, Streichert T, Macri J; IFCC Committee on Reference Intervals and Decision Limits (C-RIDL) . Distinguishing reference intervals and clinical decision limits—a review by the IFCC Committee on Reference Intervals and Decision Limits. Crit Rev Clin Lab Sci. 2018;55(6):420-431. - PubMed
    1. Nota NM, Wiepjes CM, de Blok CJM, Gooren LJG, Kreukels BPC, den Heijer M. Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy. Circulation. 2019;139(11):1461-1462. - PubMed
    1. Alzahrani T, Nguyen T, Ryan A, et al. . Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes. 2019;12(4):e005597. - PubMed
    1. van Velzen DM, Paldino A, Klaver M, et al. . Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen. J Clin Endocrinol Metab. 2019;104(6):1937-1947. - PubMed